Symbols

NNOX

Nano-x Imaging·NASDAQ

--(--)

NNOX fundamentals

NNOX Q3 2025 Earnings

Nano-x Imaging (NNOX) released its earnings on Nov 20, 2025: revenue was 3.45M (YoY +13.72%), missed estimates; EPS was -0.21 (YoY +8.70%), beat estimates.

Revenue / YoY

3.45M

+13.72%

EPS / YoY

-0.21

+8.70%

Report date

Nov 20, 2025

NNOX Earnings Call Summary for Q3,2025

2026 Revenue Target: $35M+ driven by ARC X deployment and AI expansion.
AI Acquisition: $800K VasoHealthcare IT deal to accelerate recurring revenue.
Regulatory Milestone: FDA clearance for stand-alone ARC use could unlock $100M+ U.S. market.
Financial Health: $55.5M cash on hand; AI segment to breakeven in 2026.
Product Momentum: 100+ ARC systems in pipeline, ARC X launch at RSNA 2025.

Earnings

EPS

Revenue

Revenue & Expenses

NNOX has released its 2025 Q3 earnings report, with revenue of 3.45M, reflecting a YoY change of 13.72%, and net profit of -13.68M, showing a YoY change of -0.33%. The Sankey diagram below clearly presents NNOX's revenue sources and cost distribution.

Key Indicators

Nano-x Imaging (NNOX) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Nano-x Imaging (NNOX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Nano-x Imaging (NNOX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Nano-x Imaging (NNOX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown